Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharmion and MethylGene Collaborate On Sirtuin Inhibitors To Treat Cancer

Aug 20 2007

• By Pamela Taulbee

Related Content

Novartis Prexige Is “Not Approvable;” COX-2 Launch At Least Two Years Away

Sep 29 2003

Cell Therapeutics Gets In The Groove With Systems Medicine Acquisition

Jul 25 2007

Adding Street Address To Product Label Likely In AER Guidance – CFSAN

Jun 25 2007

Gilead Letairis Will Be Available Through LEAP Restricted Distribution Program

Jun 15 2007

Novo Looking To Position Liraglutide As First Once-Daily Injection Following Oral Drug Failures

Jun 21 2007

China IND Requirements Overly Burdensome To Industry – Shanghai R&amp;D Summit

Jun 22 2007

Avandia, Actos Add Black Box; RECORD Leaves Heart Attack Risk Unresolved

Jun 11 2007

Indevus Plans End-Of-Summer NDA For Nebido Following Positive Phase III Results

Jun 07 2007

Experts Give AER Prep Course, Discuss Potential Potholes At UNPA Seminar

Jan 29 2007

Cephalon CEO Frank Baldino: An Interview With “The Pink Sheet” DAILY

Jan 09 2007

FDA Steps Up Alzheimer’s Initiatives, Plans October Stakeholders Meeting

Aug 13 2007

PDL BioPharma Product Sales Up 25 Percent On Cardene Growth

Aug 03 2007

MethylGene Gets Beta-Lactamase Inhibitor Program Back From Merck

Aug 02 2007

Updated Warfarin Label Notes Genetics’ Impact On Dosing, But Avoids Recommending Test

Aug 16 2007

CRN Disputes FDA’s Interpretation Of Labeling Requirements In AER Law

Aug 06 2007

Indevus Gains Sanctura XR Approval

Aug 06 2007

Avandia Should Stay On Market With Warnings, Committee Says

Aug 06 2007

Indevus' Supprelin LA Clears FDA As Once-Yearly Treatment For Premature Puberty

May 04 2007

Gilead Inhalation Antibiotic For Cystic Fibrosis Successful In Second Pivotal Trial

May 30 2007

Gilead Acquisition Of Corus Adds Respiratory Disease Candidate

Jul 21 2006

Iressa Gets Narrowed Indication Instead Of Withdrawal: New Model For FDA?

Jun 27 2005

Adventrx To Begin Phase III Trial Of CoFactor In Q2

May 22 2006

Alexion’s Soliris Blood Treatment Will Cost Almost $400,000 Per Year

Apr 02 2007

AHA Advises Against Antioxidant Supplementation For CHD Prevention

Aug 09 2004

Anesiva Files NDA For Zingo Topical Anesthetic

Nov 29 2006

Question-Based Review Not Raising Questions For Generic Sponsors, FDA

Nov 13 2006

Biogen Idec Is Evaluating Strategic Options For Zevalin

Oct 31 2006

Merck’s Zolinza Approved For Rare Skin Cancer

Oct 06 2006

Gilead Buys Myogen To Strengthen Pulmonology Franchise

Oct 02 2006

Bayer Suspends Senior Staffers For Failure To Disclose Trasylol Data To FDA

Oct 13 2006

Warfarin Dosing Biomarkers Could Be Model For Genetic Tests In Labeling

May 08 2006

Merck KGaA Looks To Chinese Medicine For Oncology Candidates

Nov 22 2006

Cephalon’s Fentora Approved For Breakthrough Cancer Pain

Sep 25 2006

FDA Offers Possible Reasons For Vectibix Failure To Show Survival Benefit

Apr 02 2007

Novartis Plans June Launch For Paget’s Disease Therapy Reclast

Apr 17 2007

Bayer Schering Oncology Candidate Becomes First Syndax Pipeline Compound

Apr 13 2007

Indevus Plans To Relaunch Valstar By Year-End

Apr 20 2007

Adverse Event System Success Will Depend On Trained Reporters, Experts Say

Dec 18 2006

Trasylol Not Associated With Renal/Heart Failure, MI, Stroke, Cmte. Says

Sep 21 2006

Indevus Gains Supprelin LA With Purchase Of Valera

Dec 12 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window